The estimated Net Worth of Ernst Guenter Afting is at least $555 Tisíc dollars as of 11 December 2013. Ernst Afting owns over 15,000 units of Sorrento Therapeutics Inc stock worth over $173 and over the last 15 years Ernst sold SRNE stock worth over $554,700.
Ernst has made over 2 trades of the Sorrento Therapeutics Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Ernst sold 15,000 units of SRNE stock worth $554,700 on 11 December 2013.
The largest trade Ernst's ever made was buying 360,000 units of Sorrento Therapeutics Inc stock on 21 December 2010 worth over $50,400. On average, Ernst trades about 34,091 units every 99 days since 2010. As of 11 December 2013 Ernst still owns at least 17,287 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Ernst Afting stock trades at the bottom of the page.
Ernst's mailing address filed with the SEC is C/O SORRENTO THERAPEUTICS, INC., 6042 CORNERSTONE COURT WEST, SUITE B, SAN DIEGO, CA, 92121.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee a Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: